Vaccination contre le melanome malin au moyen de bcg et/ou de vaccine
作者： Bernd Krone , Gerhard Hunsmann
DOI:
关键词:
摘要: L'invention concerne une vaccination reduisant le risque de contracter un melanome environ moitie a tiers et plus, dans periode cinq ans suivant diagnostic d'un malin, mortalite est reduit moitie, par rapport des individus non vaccines. Au-dela son effet sur melanome, la selon l'invention peut egalement presenter effets protecteurs contre d'autres malignites, telles que cancers vessie, du sein, l'oesophage reins, sarcomes lymphomes pluralite micro-organismes pouvant induire infections ou allergies graves mortelles. l'utilisation vaccin fievre jaune, aux fins prophylactique malignite, notamment quelques autres vaccinations brevetees destinees vaccins synthetiques mettant en oeuvre les motifs antigeniques identifies.
参考文章(6)
K. F. Kölmel, A. Pfahlberg, G. Mastrangelo, M. Niin, I. N. Botev, C. Seebacher, D. Schneider, D. Lambert, R. Shafir, E. M. Kokoschka, U. R. Kleeberg, B. M. Henz, O. Gefeller, Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Research. ,vol. 9, pp. 511- 520 ,(1999) , 10.1097/00008390-199910000-00011
G. Mastrangelo, C.R. Rossi, A. Pfahlberg, V. Marzia, A. Barba, M. Baldo, E. Fadda, G. Milan, K.F. Kölmel, Is there a relationship between influenza vaccinations and risk of melanoma? A population-based case-control study. European Journal of Epidemiology. ,vol. 16, pp. 777- 782 ,(2000) , 10.1023/A:1007658503740
B. Krone, K.F. Kölmel, J.M. Grange, G. Mastrangelo, B.M. Henz, I.N. Botev, M. Niin, C. Seebacher, D. Lambert, R. Shafir, E.-M. Kokoschka, U.R. Kleeberg, O. Gefeller, A. Pfahlberg, Impact of vaccinations and infectious diseases on the risk of melanoma—evaluation of an EORTC case–control study European Journal of Cancer. ,vol. 39, pp. 2372- 2378 ,(2003) , 10.1016/S0959-8049(03)00625-7
Bernd Krone, Klaus F. Kölmel, Beate M. Henz, John M. Grange, Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. European Journal of Cancer. ,vol. 41, pp. 104- 117 ,(2005) , 10.1016/J.EJCA.2004.08.010
Francesca Schiavetti, Joëlle Thonnard, Didier Colau, Thierry Boon, Pierre G Coulie, None, A Human Endogenous Retroviral Sequence Encoding an Antigen Recognized on Melanoma by Cytolytic T Lymphocytes Cancer Research. ,vol. 62, pp. 5510- 5516 ,(2002)
K.F. Kölmel, J.M. Grange, B. Krone, G. Mastrangelo, C.R. Rossi, B.M. Henz, C. Seebacher, I.N. Botev, M. Niin, D. Lambert, R. Shafir, E.-M. Kokoschka, U.R. Kleeberg, O. Gefeller, A. Pfahlberg, Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients European Journal of Cancer. ,vol. 41, pp. 118- 125 ,(2005) , 10.1016/J.EJCA.2004.09.023